Suppr超能文献

驯服野兽:丙型肝炎病毒驯化的启示。

Taming a beast: lessons from the domestication of hepatitis C virus.

机构信息

The Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, United States.

The Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, United States.

出版信息

Curr Opin Virol. 2019 Apr;35:27-34. doi: 10.1016/j.coviro.2019.02.008. Epub 2019 Mar 12.

Abstract

"What I cannot create, I do not understand." Richard Feynman may have championed reasoning from first principles in his famous blackboard missive, but he could just as well have been referring to the plight of a molecular virologist. What cannot be grown in a controlled laboratory setting, we cannot fully understand. The story of the laboratory domestication of hepatitis C virus (HCV) is now a classic example of virologists applying all manner of inventive skill to create cell-based models of infection in order to clarify prospective drug targets. In this review, we highlight key successes and failures that were instructive in achieving cell-based models for HCV studies and drug development. We also emphasize the lessons learned from the ∼40 year saga that may be applicable to viruses yet unknown and uncultured.

摘要

“我不能创造的东西,我就无法理解。”理查德·费曼(Richard Feynman)在他著名的黑板便条中可能倡导了从第一原理进行推理,但他也可能指的是分子病毒学家的困境。在可控的实验室环境中无法生长的东西,我们就无法完全理解。丙型肝炎病毒(HCV)的实验室驯化故事现在是病毒学家应用各种创造性技能来创建基于细胞的感染模型以阐明潜在药物靶点的经典范例。在这篇综述中,我们强调了在建立基于细胞的 HCV 研究和药物开发模型方面具有启发性的关键成功和失败。我们还强调了从这个约 40 年的传奇故事中吸取的经验教训,这些经验教训可能适用于未知和未培养的病毒。

相似文献

1
Taming a beast: lessons from the domestication of hepatitis C virus.驯服野兽:丙型肝炎病毒驯化的启示。
Curr Opin Virol. 2019 Apr;35:27-34. doi: 10.1016/j.coviro.2019.02.008. Epub 2019 Mar 12.
2
Hepatitis C virus virology and new treatment targets.丙型肝炎病毒病毒学与新的治疗靶点
Expert Rev Anti Infect Ther. 2009 Apr;7(3):329-50. doi: 10.1586/eri.09.12.
3
Emerging antiviral drugs for hepatitis C virus.用于丙型肝炎病毒的新型抗病毒药物。
Rev Recent Clin Trials. 2009 Sep;4(3):179-84. doi: 10.2174/157488709789957628.
5
Virology of hepatitis B and C viruses and antiviral targets.乙型和丙型肝炎病毒的病毒学及抗病毒靶点
J Hepatol. 2006;44(1 Suppl):S10-3. doi: 10.1016/j.jhep.2005.11.005. Epub 2005 Nov 21.
6
Novel hepatitis C drugs in current trials.当前试验中的新型丙型肝炎药物。
Clin Liver Dis. 2008 Aug;12(3):529-55, viii. doi: 10.1016/j.cld.2008.03.001.
7
Hepatitis C virus entry.丙型肝炎病毒进入。
Curr Top Microbiol Immunol. 2013;369:87-112. doi: 10.1007/978-3-642-27340-7_4.
9
Novel therapies for hepatitis C - one pill fits all?新型丙型肝炎治疗方法——一药通用?
Nat Rev Drug Discov. 2013 Aug;12(8):595-610. doi: 10.1038/nrd4050. Epub 2013 Jun 28.
10
Novel therapies for hepatitis C virus based on lessons from virology.基于病毒学经验教训的丙型肝炎病毒新型疗法。
Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S86-8. doi: 10.1016/s1542-3565(05)00703-2.

引用本文的文献

5
Viral hepatitis update: Progress and perspectives.病毒性肝炎最新进展:成就与展望。
World J Gastroenterol. 2021 Jul 14;27(26):4018-4044. doi: 10.3748/wjg.v27.i26.4018.

本文引用的文献

4
Zika virus vaccines.寨卡病毒疫苗。
Nat Rev Microbiol. 2018 Oct;16(10):594-600. doi: 10.1038/s41579-018-0039-7.
5
Protease inhibitor therapy for hepatitis C virus-infection.蛋白酶抑制剂治疗丙型肝炎病毒感染。
Expert Opin Pharmacother. 2018 Apr;19(6):577-587. doi: 10.1080/14656566.2018.1454428. Epub 2018 Mar 29.
6
Rewiring cellular networks by members of the Flaviviridae family.黄病毒科成员对细胞网络的重排。
Nat Rev Microbiol. 2018 Feb 12;16(3):125-142. doi: 10.1038/nrmicro.2017.170.
8
Zika Virus Pathogenesis and Tissue Tropism.寨卡病毒发病机制与组织嗜性
Cell Host Microbe. 2017 Feb 8;21(2):134-142. doi: 10.1016/j.chom.2017.01.004.
10
Enter Sofosbuvir: The Path to Curing HCV.索非布韦登场:治愈丙型肝炎之路。
Cell. 2016 Sep 22;167(1):25-29. doi: 10.1016/j.cell.2016.08.044. Epub 2016 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验